BioCentury | Apr 15, 2013
Company News

Houston Biotechnology, Medarex deal

...23). MEDX issued 0.182 common shares for each of the 5.6 million shares of HBI. Houston Biotechnology Inc....
BioCentury | Dec 23, 1996
Company News

Houston Biotechnology, Medarex deal

...has 17.6 million shares outstanding prior to the merger. HBI closed the week at $1.187. Houston Biotechnology Inc....
BioCentury | Dec 16, 1996
Company News

Houston Biotechnology, Medarex deal

...0.182 shares of stock in exchange for each of the 5.6 million shares of HBI. Houston Biotechnology Inc....
BioCentury | Dec 16, 1996
Analyst Picks & Changes

Analyst picks & changes

...Alex. Brown analyst Kevin Tang repeated a "strong buy" after MEDX announced plans to buy Houston Biotechnology...
BioCentury | Jan 8, 1996
Company News

Houston Biotechnology, Santen Pharmaceutical Co. Ltd deal

...Once approved, Santen will purchase the product from HBI and will pay royalties on sales. Houston Biotechnology Inc....
BioCentury | Nov 20, 1995
Company News

Houston Biotechnology, Santen deal

...occurs in 50 percent of primary cataract patients within three to five years following surgery. Houston Biotechnology Inc....
BioCentury | Sep 5, 1995
Company News

Houston Biotechnology other research news

...the National Eye Institute to develop polymer implants to deliver agents that inhibit cell growth. Houston Biotechnology Inc....
BioCentury | Feb 6, 1995
Company News

Houston Biotechnology news

...in early stage research. Programs in glaucoma and proliferative vitreoretinopathy will be put on hold. Houston Biotechnology Inc....
BioCentury | Oct 31, 1994
Clinical News

4197X-RA immunotoxin to destroy lens epithelial cells in the eye data

...treatment in four to seven weeks. Follow-up will continue for a total of two years. Houston Biotechnology Inc....
BioCentury | Oct 3, 1994
Company News

Genentech, Houston Biotechnology deal

...Under the agreement, Alcon will conduct in vitro and in vivo tests. Genentech Inc. (GNE) Houston Biotechnology Inc....
Items per page:
1 - 10 of 10
BioCentury | Apr 15, 2013
Company News

Houston Biotechnology, Medarex deal

...23). MEDX issued 0.182 common shares for each of the 5.6 million shares of HBI. Houston Biotechnology Inc....
BioCentury | Dec 23, 1996
Company News

Houston Biotechnology, Medarex deal

...has 17.6 million shares outstanding prior to the merger. HBI closed the week at $1.187. Houston Biotechnology Inc....
BioCentury | Dec 16, 1996
Company News

Houston Biotechnology, Medarex deal

...0.182 shares of stock in exchange for each of the 5.6 million shares of HBI. Houston Biotechnology Inc....
BioCentury | Dec 16, 1996
Analyst Picks & Changes

Analyst picks & changes

...Alex. Brown analyst Kevin Tang repeated a "strong buy" after MEDX announced plans to buy Houston Biotechnology...
BioCentury | Jan 8, 1996
Company News

Houston Biotechnology, Santen Pharmaceutical Co. Ltd deal

...Once approved, Santen will purchase the product from HBI and will pay royalties on sales. Houston Biotechnology Inc....
BioCentury | Nov 20, 1995
Company News

Houston Biotechnology, Santen deal

...occurs in 50 percent of primary cataract patients within three to five years following surgery. Houston Biotechnology Inc....
BioCentury | Sep 5, 1995
Company News

Houston Biotechnology other research news

...the National Eye Institute to develop polymer implants to deliver agents that inhibit cell growth. Houston Biotechnology Inc....
BioCentury | Feb 6, 1995
Company News

Houston Biotechnology news

...in early stage research. Programs in glaucoma and proliferative vitreoretinopathy will be put on hold. Houston Biotechnology Inc....
BioCentury | Oct 31, 1994
Clinical News

4197X-RA immunotoxin to destroy lens epithelial cells in the eye data

...treatment in four to seven weeks. Follow-up will continue for a total of two years. Houston Biotechnology Inc....
BioCentury | Oct 3, 1994
Company News

Genentech, Houston Biotechnology deal

...Under the agreement, Alcon will conduct in vitro and in vivo tests. Genentech Inc. (GNE) Houston Biotechnology Inc....
Items per page:
1 - 10 of 10